TL;DR
We tested seven AI-assisted investment research tools across three months of active use. For most retail investors, the combination of Perplexity Finance (free), Stockanalysis.com (free), and a TradingView Pro subscription (~$15/mo) covers 80% of research needs at a fraction of institutional costs. Danelfin adds useful AI scoring if you're systematic about factor-based screening. Skip Bloomberg Terminal unless your employer is paying.
How We Evaluated {#methodology}
We evaluated tools across five dimensions: data freshness, AI explanation quality, screening capabilities, value for cost, and actual utility in a real portfolio context. We used each tool for at least four weeks before rating. Scores below reflect our independent assessment; where third-party ratings exist (G2, Trustpilot), we've included them for reference.
Tools excluded: platforms requiring $5,000+ annual contracts (Bloomberg, FactSet, Refinitiv), crypto-only tools, and platforms that had fewer than 100 documented user reviews as of March 2026.
The Tools We Tested
Perplexity Finance
Perplexity's Finance mode gives instant AI-generated summaries of earnings reports, analyst upgrades, and macro news. Type "NVDA Q4 2025 earnings analysis" and it returns a cited summary with source links in under 10 seconds.
| Feature | Details |
|---|---|
| Free tier | Yes — unlimited questions, finance mode included |
| Paid tier | Pro $20/month (faster, more sources, image analysis) |
| Data freshness | Near real-time (indexes news and filings within hours) |
| G2 Rating | 4.5/5 (380+ reviews as of Q1 2026) |
| Best for | Rapid news synthesis, earnings call summarization |
What works: The speed-to-insight ratio is hard to beat. For news aggregation and rapid fundamental context, Perplexity Finance outperforms dedicated finance tools costing 10x more.
Genuine limitation: It synthesizes existing sources — it doesn't generate original analysis. If consensus is wrong, Perplexity will reflect that wrongness. Also lacks screener functionality entirely.
Danelfin
Danelfin scores stocks 0-10 using a machine learning model trained on 900+ technical, fundamental, and sentiment indicators. The platform publishes backtested win rates for each score tier — stocks scoring 10/10 have historically outperformed the S&P 500 in 12-month windows, per their own published data.
| Feature | Details |
|---|---|
| Free tier | Limited (top 10 scores visible, no screening) |
| Paid tier | ~$20/month (Basic), ~$49/month (Pro) |
| Data coverage | US and European equities |
| Score validity | Daily updates, backtested to 2017 |
| Capterra Rating | 4.3/5 |
| Best for | Systematic factor scoring, holding period 1-12 months |
What works: The score is transparent — you can see which sub-factors (momentum, value, quality) are driving each stock's rating. This is more useful than black-box AI recommendations that don't show their work.
Genuine limitation: Backtested performance is not forward performance. The model has never navigated a full credit cycle. Score-10 stocks in 2022 underperformed significantly when the rate environment shifted — a gap between historical testing and live conditions you should factor in.
TipRanks
TipRanks aggregates analyst ratings, hedge fund filings, and insider transactions into a "Smart Score" (1-10). Its AI News Tool summarizes earnings calls and analyst notes.
| Feature | Details |
|---|---|
| Free tier | 5 stock searches/month, limited historical data |
| Paid tier | Premium $29.95/month, Ultimate $49.95/month |
| Analyst coverage | 10,000+ analysts tracked, rated by historical accuracy |
| G2 Rating | 4.4/5 (220+ reviews) |
| Best for | Analyst consensus, insider activity, news summarization |
What works: Analyst accuracy tracking is genuinely useful — TipRanks shows each analyst's historical hit rate, which lets you weight recommendations by track record rather than treating all analysts equally.
Genuine limitation: Smart Score is consensus-driven. It will be bullish on stocks that are broadly bullish, which provides little contrarian value. During the 2021 tech bubble, Smart Scores for SPAC stocks were high because analysts were universally positive.
Stockanalysis.com
Not AI-first, but a comprehensive free resource for fundamental data: income statements going back 10 years, segment breakdowns, DCF calculators, ETF holdings. One of the most data-dense free financial tools available.
| Feature | Details |
|---|---|
| Free tier | Extensive — 10-year financials, ETF data, screener basics |
| Paid tier | $49/year (more screener filters, bulk data export) |
| Data coverage | US, Canadian, and Australian equities + 2,000+ ETFs |
| Trustpilot Rating | 4.7/5 |
| Best for | Fundamental research, historical data, quick DCF estimates |
What works: For checking whether a company's revenue growth has been consistent, margins are improving, and debt is manageable — Stockanalysis delivers faster than any Bloomberg terminal we've used.
Genuine limitation: No predictive analytics, no AI-generated insights beyond basic metrics. It's a data layer, not a recommendation engine.
TradingView
TradingView is primarily a charting platform, but its AI features and screening capabilities make it relevant for research, not just technical analysis.
| Feature | Details |
|---|---|
| Free tier | Limited charts, no real-time data |
| Paid tier | Essential $15/mo, Plus $30/mo, Premium $60/mo |
| AI features | Smart Patterns, earnings estimator, AI summary on news |
| G2 Rating | 4.5/5 (490+ reviews) |
| Best for | Technical setup validation, multi-asset screening, charting |
We use TradingView as the connective tissue between fundamental research (Stockanalysis) and final trade setup. The screener can filter by hundreds of fundamental and technical criteria simultaneously — something that takes minutes in Excel but seconds in TradingView.
Genuine limitation: The AI summary features on news articles are serviceable but not exceptional — Perplexity Finance provides more detailed AI analysis of earnings events. TradingView's value is in its chart quality and screener depth, not AI text synthesis.
Simply Wall St
Simply Wall St uses visual "snowflake" diagrams to summarize a company's value, future outlook, past performance, financial health, and dividends into a single visual.
| Feature | Details |
|---|---|
| Free tier | Limited (2 stocks detailed view) |
| Paid tier | ~$10/month (individual), ~$20/month (investor) |
| Coverage | 50,000+ stocks globally |
| Trustpilot Rating | 4.1/5 |
| Best for | Quick visual health checks, portfolio exposure mapping |
What works: The visual format makes it fast to identify obvious red flags (deteriorating balance sheet, negative free cash flow trend) across a watchlist of 20+ stocks.
Genuine limitation: Analysis depth is limited — the snowflake gives a directional signal but won't catch nuanced issues like accounting adjustments or off-balance-sheet liabilities.
Koyfin
Koyfin is described as "Bloomberg for retail" — comprehensive macroeconomic dashboards, earnings model templates, and comparative analytics at a fraction of institutional pricing.
| Feature | Details |
|---|---|
| Free tier | Yes — 60+ dashboard widgets, limited historical data |
| Paid tier | Plus $49/month, Pro $99/month |
| Data depth | Macro data, corporate filings, estimates, earnings history |
| G2 Rating | 4.6/5 (190+ reviews) |
| Best for | Macro research, custom dashboards, earnings modeling |
What works: The macro dashboard is genuinely Bloomberg-quality for monitoring economic indicators, yield curves, and sector rotation. For building earnings models with quarterly estimates, Koyfin is faster than building from scratch in Excel.
Genuine limitation: The learning curve is steep — it takes 2-3 weeks to build useful dashboards. The free tier is functional but the data depth that makes Koyfin valuable requires paid access.
Direct Comparison
| Tool | Best For | Free? | Cost | Data Depth | AI Quality |
|---|---|---|---|---|---|
| Perplexity Finance | News synthesis | ✅ | $20/mo (Pro) | Medium | High |
| Danelfin | Factor scoring | Limited | ~$20/mo | High | High |
| TipRanks | Analyst tracking | Limited | $30/mo | High | Medium |
| Stockanalysis | Fundamentals | ✅ | $49/yr | Very High | Low (data only) |
| TradingView | Charting + screening | Limited | $15-60/mo | High | Medium |
| Simply Wall St | Visual health check | Limited | ~$10/mo | Medium | Medium |
| Koyfin | Macro + modeling | Limited | $49-99/mo | Very High | Medium |
Which Combination Makes Sense
Budget (~$0-20/month): Perplexity Finance + Stockanalysis.com + TradingView free + Simply Wall St free. This covers rapid news synthesis, deep fundamental data, and visual health checks at near-zero cost.
Systematic investor (~$40-60/month): Add Danelfin Basic and TradingView Essential. Danelfin adds scoring discipline; TradingView adds real-time screener and charting.
Active trader / researcher (~$80-120/month): TradingView Premium + TipRanks Premium + Koyfin Plus. Covers charting, analyst tracking, and macro modeling comprehensively.
Genuine Downsides of AI Research Tools (All of Them)
- Garbage-in, garbage-out: AI tools process what companies disclose. Creative accounting, SPE structures, and management guidance manipulation all pass through the filter unchallenged.
- Consensus amplification: AI scoring tools trained on market data encode the market's existing biases. They'll be bullish at tops and bearish at bottoms.
- Backtesting is not live testing: Most AI research tools publish impressive backtested returns. None of them have been tested through a prolonged credit tightening cycle, a geopolitical supply shock, and a pandemic simultaneously.
- Data lag is real: Even "real-time" tools have 15-minute to end-of-day delays depending on your plan tier.
FAQ
Which free AI research tool provides the most value?
Stockanalysis.com and Perplexity Finance are the strongest free options. Stockanalysis provides deep fundamental data including 10-year income statements, balance sheets, and ETF holdings with no paywall. Perplexity Finance synthesizes news and earnings events rapidly. Using both together covers most retail investor research needs without any subscription cost.
Is Danelfin worth paying for?
For systematic investors who apply factor-based criteria consistently, yes. Danelfin's score transparency (showing which sub-factors drive each rating) is more useful than black-box tools. The caveat: backtested win rates don't guarantee forward performance, and the model has limited live history through diverse market regimes.
How does TradingView compare to Bloomberg Terminal for research?
Bloomberg Terminal offers unmatched data breadth, real-time fixed income data, proprietary analytics, and professional-grade news feeds — but costs roughly $25,000/year. TradingView at $15-60/month covers equity charting, screening, and technical analysis well, but lacks fixed income analytics, proprietary corporate data, and the news depth of Bloomberg. For most retail and semi-professional investors, TradingView plus Koyfin provides 70-80% of Bloomberg's utility at under 1% of the cost.
Can AI research tools replace a financial advisor?
No. AI research tools excel at data synthesis, pattern recognition, and screening large universes of stocks quickly. They don't account for personal tax situations, estate planning, insurance needs, behavioral coaching, or the liability and fiduciary responsibility that come with professional advice. Use them to become a more informed investor, not to replace professional guidance when complexity warrants it.
Data and pricing reflect March 2026. Subscription costs change frequently — verify current pricing at each platform before subscribing. This article is for informational purposes only and does not constitute investment advice.